» Articles » PMID: 38632615

DNA-based Molecular Classifiers for the Profiling of Gene Expression Signatures

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2024 Apr 17
PMID 38632615
Authors
Affiliations
Soon will be listed here.
Abstract

Although gene expression signatures offer tremendous potential in diseases diagnostic and prognostic, but massive gene expression signatures caused challenges for experimental detection and computational analysis in clinical setting. Here, we introduce a universal DNA-based molecular classifier for profiling gene expression signatures and generating immediate diagnostic outcomes. The molecular classifier begins with feature transformation, a modular and programmable strategy was used to capture relative relationships of low-concentration RNAs and convert them to general coding inputs. Then, competitive inhibition of the DNA catalytic reaction enables strict weight assignment for different inputs according to their importance, followed by summation, annihilation and reporting to accurately implement the mathematical model of the classifier. We validated the entire workflow by utilizing miRNA expression levels for the diagnosis of hepatocellular carcinoma (HCC) in clinical samples with an accuracy 85.7%. The results demonstrate the molecular classifier provides a universal solution to explore the correlation between gene expression patterns and disease diagnostics, monitoring, and prognosis, and supports personalized healthcare in primary care.

Citing Articles

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma.

Chan Y, Zhang C, Wu J, Lu P, Xu L, Yuan H Mol Cancer. 2024; 23(1):189.

PMID: 39242496 PMC: 11378508. DOI: 10.1186/s12943-024-02101-z.

References
1.
Koscielny S . Why most gene expression signatures of tumors have not been useful in the clinic. Sci Transl Med. 2010; 2(14):14ps2. DOI: 10.1126/scitranslmed.3000313. View

2.
Mills Jr A . Gene expression profiling diagnosis through DNA molecular computation. Trends Biotechnol. 2002; 20(4):137-40. DOI: 10.1016/s0167-7799(01)01915-1. View

3.
Domany E . Using high-throughput transcriptomic data for prognosis: a critical overview and perspectives. Cancer Res. 2014; 74(17):4612-21. DOI: 10.1158/0008-5472.CAN-13-3338. View

4.
Broza Y, Zhou X, Yuan M, Qu D, Zheng Y, Vishinkin R . Disease Detection with Molecular Biomarkers: From Chemistry of Body Fluids to Nature-Inspired Chemical Sensors. Chem Rev. 2019; 119(22):11761-11817. DOI: 10.1021/acs.chemrev.9b00437. View

5.
Zhang D . Cooperative hybridization of oligonucleotides. J Am Chem Soc. 2010; 133(4):1077-86. DOI: 10.1021/ja109089q. View